Navigation Links
Bausch & Lomb, Santen Strike Licensing Agreement for IOL Development
Date:3/2/2009

ALISO VIEJO, Calif., March 3 /PRNewswire/ -- Bausch & Lomb, the global eye health company, has entered into a licensing agreement with Santen Pharmaceutical Co., Ltd., for the development of certain intraocular lens (IOL) materials.

Under the terms of the agreement, Bausch & Lomb has obtained the rights to Santen's hydrophobic acrylic polymers, from which it may commercialize new IOLs for sale worldwide. Santen reserves the right for the use of these materials in the Japanese market. Financial terms will not be disclosed.

"Bausch & Lomb is enthusiastic about the potential that these polymers hold for developing next-generation IOLs, to benefit patients and surgeons alike," said John Sheets, Jr., Ph.D., corporate vice president and chief technology officer, Bausch & Lomb. "We are committed to aggressively creating innovative, in-demand products through both industry partnerships and our considerable internal capabilities. Combining these materials with our current product and technology portfolio will provide Bausch & Lomb with an unsurpassed breadth of product offerings."

"Developing these novel materials extends our access to the global IOL marketplace, complementing our existing Crystalens(R), Akreos(TM) and SofPort(R) IOL products," noted Tom Frinzi, vice president, Global Commercial Operations, Surgical, Bausch & Lomb.

Bausch & Lomb is one of the world's leading developers and manufacturers of IOLs, which are used to replace the eye's natural crystalline lens during cataract surgery. Its Crystalens product is the only FDA-approved accommodating IOL, flexing like the eye's natural lens to allow patients to see better at all distances.

About Bausch & Lomb

Bausch & Lomb is the eye health company dedicated to perfecting vision and enhancing life for people around the world. Its core businesses include contact lenses and lens care products, ophthalmic surgical devices and instruments, and ophthalmic pharmaceuticals. Bausch & Lomb is one of the best-known and most respected healthcare brands in the world. Founded in 1853, the company is headquartered in Rochester, N.Y. Its products are available in more than 100 countries. More information is available at www.bausch.com.

Akreos, SofPort, and Crystalens are trademarks of Bausch & Lomb Incorporated.


'/>"/>
SOURCE Bausch & Lomb
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Bausch & Lomb Survey Shows People with Astigmatism Unaware of Contact Lens Options
2. Bausch & Lombs Crystalens to be Featured in Florida Advertising Campaign.
3. Bausch & Lomb Names Peter Valenti, III, as President, North America, Vision Care
4. Young Women Learn to Strike a Balance Between Breast Cancer and Careers
5. Registered Nurses and Licensed Practical Nurses at Innova Deptford and Innova Hammonton are Set to Strike at 6 a.m. Friday January 23
6. U.S. Preventive Medicine(R) Strikes a Note with Broadcast Music, Inc.
7. Strike It Healthy Family Fits Trends for Coming Year
8. Strikeithealthyfamily.com Provides Parents With Sense of Relief
9. University Hospitals Geneva Medical Center Registered Nurses to Strike on December 10 if Contract Agreement Cannot Be Reached
10. Panamanian termite goes ballistic: Fastest mandible strike in the world
11. Quintet of proteins forms new, early-warning blood test before heart attack strikes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma community ... will return to the La Gorce Country Club in Miami Beach to host ...
(Date:2/23/2017)... ... 2017 , ... Los Angeles-based weight loss surgeon Michael Feiz, M.D., F.AC.S. will ... to Hot,” which will begin airing on February 24, 2017. The show chronicles the ... 2012 reality television series, “Here Comes Honey Boo Boo.” The earlier series from TLC ...
(Date:2/23/2017)... IPSWICH, Mass. (PRWEB) , ... February 23, 2017 ... ... chosen as an approved content provider for the National Institute for Health ... care and social care-related organizations in the National Health Service (NHS) to search, ...
(Date:2/23/2017)... Denver, Colorado (PRWEB) , ... February 23, 2017 ... ... Dialog Magazine, an exciting, new, interactive publication where generations converge and explore the ... to expand their worldview, Dialog Magazine enables readers to gain understanding, increase empathy, ...
(Date:2/23/2017)... ... 23, 2017 , ... Healthcare Research & Analytics® (HRA®) in ... against cancer, has produced a seminal study that asked cancer survivors and their ... in a webinar, Defining Compassionate Care Through the Voices of Patients and Advocates ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... , Feb 23, 2017 Research and ... Devices Market Analysis & Trends - Industry Forecast to 2025" ... ... grow at a CAGR of around 9.2% over the next decade ... report analyzes the market estimates and forecasts for all the given ...
(Date:2/23/2017)... SAN DIEGO , Feb. 23, 2017 /PRNewswire/ ... MBVX), a clinical-stage oncology drug development company, announces ... Food and Drug Administration (FDA) authorizing the initiation ... a therapeutic treatment for pancreatic cancer. MVT-1075 ( ... antibody radioimmunotherapy (RIT). MabVax plans to initiate the ...
(Date:2/23/2017)... Orthopedic and cardiac devices will continue ... patterns lead to an increasing prevalence of musculoskeletal ... injuries, chronic back problems, heart valve replacement, and ... future of medical implants faces many uncertainties. ... more: - What types of medical implants ...
Breaking Medicine Technology: